[Glioblastoma in 2017]
1Hôpital Gui de Chauliac, CHU de Montpellier, 80 avenue Augustin-Fliche, 34 000 Montpellier, France; INSERM U1051, Institut des neurosciences de Montpellier, Hôpital Saint Eloi, CHU de Montpellier, 80 avenue Augustin-Fliche, 34 000 Montpellier, France.
Revue De L'Infirmiere
|February 6, 2017
Abstract:
Glioblastomas are serious tumours of the central nervous system. Recurrence is systematic and prognosis poor. Radiotherapy and chemotherapy follow surgery, when surgery is possible, to lengthen survival, while preserving quality of life as much as possible. In this respect, symptomatic treatments and supportive care are necessary.
